|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.930 INR | +2.27% |
|
-2.26% | -30.56% |
| Market Cap | 1.73B 18.16M 15.89M 14.65M 13.53M 25.68M 26.11M 175M 68.76M 853M 68.19M 66.71M 2.93B | P/E 2024 |
26x | P/E 2025 | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.46B 15.28M 13.37M 12.33M 11.39M 21.61M 21.97M 147M 57.85M 718M 57.38M 56.13M 2.47B | EV / Sales 2024 |
3.67x | EV / Sales 2025 | 1.79x |
| Free-Float |
65.03% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.27% | ||
| 1 week | -2.26% | ||
| Current month | -7.37% | ||
| 1 month | -1.10% | ||
| 3 months | -3.31% | ||
| 6 months | -26.77% | ||
| Current year | -30.56% |
| 1 week | 8.65 | 10.48 | |
| 1 month | 8.65 | 12.5 | |
| Current year | 7.05 | 14.77 | |
| 1 year | 7.05 | 17.25 | |
| 3 years | 6.15 | 29 | |
| 5 years | 4.81 | 29 | |
| 10 years | 1.32 | 29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CEO | Chief Executive Officer | 40 | 17/05/2012 |
| Director of Finance/CFO | - | 11/11/2024 | |
| Compliance Officer | 62 | 19/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 29/05/2025 | |
Arihant Baid
CHM | Chairman | 40 | - |
| Director/Board Member | - | 20/12/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.27% | -2.26% | -31.94% | +41.86% | 25.29M | ||
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | ||
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | ||
| -0.73% | -4.98% | +28.91% | +82.99% | 438B | ||
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | ||
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | ||
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | ||
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | ||
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | ||
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | ||
| Average | -0.83% | -3.15% | +20.86% | +55.22% | 357.39B | |
| Weighted average by Cap. | -1.31% | -2.96% | +36.75% | +83.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 867M 9.09M 7.95M 7.34M 6.78M 12.86M 13.07M 87.65M 34.42M 427M 34.14M 33.4M 1.47B | 1.38B 14.46M 12.65M 11.67M 10.77M 20.44M 20.79M 139M 54.74M 679M 54.29M 53.11M 2.34B |
| Net income | 132M 1.38M 1.21M 1.11M 1.03M 1.95M 1.99M 13.32M 5.23M 64.9M 5.19M 5.07M 223M | 181M 1.9M 1.66M 1.53M 1.42M 2.69M 2.73M 18.32M 7.19M 89.28M 7.13M 6.98M 307M |
| Net Debt | -413M -4.33M -3.79M -3.49M -3.23M -6.12M -6.22M -41.74M -16.39M -203M -16.26M -15.9M -699M | -275M -2.88M -2.52M -2.32M -2.15M -4.07M -4.14M -27.77M -10.91M -135M -10.82M -10.58M -465M |
Employees
115
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | ₹9.930 | +2.27% | 400,152 |
| 09/07/26 | ₹9.710 | +7.06% | 520,187 |
| 08/07/26 | ₹9.070 | -9.57% | 1,024,635 |
| 07/07/26 | ₹10.03 | -2.05% | 470,870 |
| 06/07/26 | ₹10.24 | +0.79% | 215,120 |
- Stock Market
- Stocks
- GENNEX6 Stock
Select your edition
All financial news and data tailored to specific country editions
















